 |
This Is MS Multiple Sclerosis Community: Knowledge & SupportWelcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones. |
| It is currently Tue Jun 18, 2013 7:39 pm |
|
All times are UTC - 8 hours [ DST ] |
 
|
Page 1 of 1 |
[ 1 post ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| squiffy2 |
|
|||||
Joined: Wed Oct 14, 2009 3:00 pm Posts: 1711 |
|
|||||
| Top |  |
|||||
 |
||||||
|
|
Page 1 of 1 |
[ 1 post ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
 | Emerging therapeutic targets | 0 | 749 | Tue May 30, 2006 10:23 am | |
| 40+ MRF myelin repair targets being studied for non-MS | 0 | 694 | Mon Jan 10, 2011 8:59 pm | |
| MiRNAs possible biomarkers, treatment targets in MS | 0 | 656 | Mon Jun 06, 2011 3:19 am | |
 | Fatty liver & inflammation: my new targets | 10 | 866 | Tue Sep 11, 2012 6:09 pm | |
| Laquinimod targets immune cells to increase neuroprotection | 3 | 550 | Thu Dec 08, 2011 10:35 am | |
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |
News 
Site map 
SitemapIndex 
RSS Feed Channel list
Login
Register
FAQ
